Oruka Therapeutics, Inc. (ORKA) › Capital ExpendituresOruka Therapeutics, Inc. (ORKA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $4.0K2011: $19.0K2013: $32.0K2014: $19.0K2015: $11.0K2016: $12.0K2017: $3.0K2018: $4.0K2019: $4.0K2020: $19.0K2021: $43.0K2022: $2.0K2023: $02025: $209.0K$209.0K2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$209.0K—2023$0-100.0%2022$2.0K-95.3%2021$43.0K+126.3%2020$19.0K+375.0%2019$4.0K+0.0%2018$4.0K+33.3%2017$3.0K-75.0%2016$12.0K+9.1%2015$11.0K-42.1%2014$19.0K-40.6%2013$32.0K—2011$19.0K+375.0%2010$4.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share